Phase 3 of the clinical trials of Kazakhstan’s QazCovid-in will be 50% complete on April 15
Scientists of Kazakhstan’s Research Institute for Biological Safety Problems are aiming at developing a vaccine against COVID-19 for animals, Kazinform reports.
Читайте также
According to Miras Daulenov, Vice-Minister of Education and Science of Kazakhstan, the Research Institute for Biological Safety Problems is tasked with the development of a vaccine against COVID-19 for animals as they also can catch and carry the disease.
He pointed out the importance of such a vaccine.
Notably, phase 3 of the clinical trials of Kazakhstan’s QazCovid-in will be 50% complete on April 15.
Photo: gazeta.ru.
